Enanta Pharmaceuticals, a research and development-focused biotechnology company has announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public of $14.00 per share. Enanta is backed by Advent International, AlpInvest Partners, Alpha Associates, BioVentures Investors, Global Biomedical Partners, Lancet Capital, Oxford Bioscience Partners, TVM Capital and Wheatley Partners.
You are browsing the archive for AlpInvest Partners - peHUB.
This week, peHub is showcasing a job vacancy for a vice president within the Goldman Sachs Alternative Investments & Manager Selection Group.
AlpInvest Partners is expanding its Hong Kong office with a dedicated secondary investments team. The secondaries team in Asia will be helmed by Neal Costello, who recently relocated from the firm’s New York office. He will be joined by Nicole Ying Su, who moved from the AlpInvest secondary investments team in Amsterdam. PRESS RELEASE AlpInvest [...]
TV ratings firm Nielsen Holdings has launched a follow-on offering that will allow its private-equity backers to sell as much as $760 million worth of shares, according to Reuters‘ publication IFR. The offering will allow private equity backers Blackstone, Carlyle, KKR, Thomas H. Lee, Hellman & Friedman, AlpInvest Partners and Centerview Capital to sell down [...]
(Reuters) – David M. Rubenstein, co-founder of buyout firm Carlyle, said Asia’s private equity industry will likely rise to challenge U.S. and European dominance of the sector over the next five to 10 years. Rubenstein, who co-founded Carlyle in 1987, said he expects some of China’s current crop of private equity firms to rival U.S. [...]
Today’s big news is that AXA has put its private equity fund manager up for sale.
Credit Suisse is advising on the sale, according to my coworkers at Thomson Reuters. AXA PE could be valued at roughly 500 million Euros or $672 million, Bloomberg News says. Sky News, which first reported the sale, says AXA PE could fetch $1.5 billion.
Paris-based AXA PE manages roughly $28 billion of assets. The unit is part of AXA Investment Managers.
Who would be interested? The most likely buyer is the Carlyle Group which inked a similar deal earlier this year, sources say. Washington D.C.-based Carlyle agreed to buy a 60% stake in AlpInvest Partners, a fund of fund firm that also makes direct investments, earlier this year. AlpInvest had 32.3 billion Euros (US$43.3 billion) in assets at the time. Harbourvest Partners and Grosvenor Capital Management had reportedly bid for AlpInvest but lost, according to press reports.
Dutch private equity firm AlpInvest Partners will be bought by a joint venture between the Carlyle Group and AlpInvest’s management, Reuters reported. Financial terms were not released. Two Dutch pension managers, APG and PGGM, are selling their stakes in AlpInvest, but will continue to commit funds to the group, Reuters said. AlpInvest has more than 40 billion euros in funds and commitments.
PE Mega-Deal: AlpInvest Partners is sold to Carlyle in €32.3B deal
Going Public: Nielsen, and at a higher price than initially anticipated
It’s Venture Capital!: It’s speed dating! It’s both! Make your pitch to the pros
Nobody Doesn’t Like Sara Lee: But that doesn’t mean Sara Lee’s got to like you back, PE
Murdoch: The media titan flakes on Davos as his BSkyB bid is threatened